CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Early initiation of Empagliflozin in the full spectrum of HF

Document ID: PC-PH-104579

27/03/2023

Author: Boehringer Ingelheim

Related content

 
PC-PH-104579
Production date: March 2023